Evidence map›Paper›PMID 30515701›Full record

ArticleJournal of molecular neuroscience : MN2019

Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons.

Erdinç Dursun, Esin Candaş, Selma Yılmazer, Duygu Gezen-Ak

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Erdinç DursunBrain and Neurodegenerative Disorders Research Laboratory, Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Istanbul, Turkey.
Esin CandaşBrain and Neurodegenerative Disorders Research Laboratory, Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Istanbul, Turkey.
Selma YılmazerDepartment of Medical Biology, Faculty of Medicine, Altinbas University, Istanbul, Turkey.
Duygu Gezen-AkBrain and Neurodegenerative Disorders Research Laboratory, Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Istanbul, Turkey. duygugezenak@gmail.com.ORCID http://orcid.org/0000-0001-7611-2111
Istanbul University-Cerrahpaşa · TRAltınbaş University · TR

Funding

Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi 21585Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 214S585
6 · The paper itself

Abstract

Recently, Aβ1-42 was demonstrated to have the potential to translocate into the nucleus and to be involved in the transcriptional regulation of certain neurodegeneration-related genes. This data raises the question of whether Aβ-induced neurodegeneration might include the expression of miRNAs. Thus, our aim in this study was to investigate the effects of Aβ1-42 on certain miRNAs which are related with vitamin D metabolism, neuronal differentiation, development, and memory. This question was investigated in primary cortical neurons that were treated with 10 μM Aβ and/or 10

Indexed as

Amyloid beta-PeptidesAnimalsCells, CulturedMicroRNAsNeuronsPeptide FragmentsRatsRats, Sprague-DawleyVitamin DAmyloid beta-Peptidesamyloid beta-protein (1-42)MicroRNAsPeptide FragmentsVitamin DAlzheimer’s diseaseAβmiRNAVitamin DVitamin D receptor (VDR)

Identifiers

PMID30515701
OpenAlexW2902624642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.